Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 3,976 | 3,890 | 8,760 | 3,099 | 9,437 |
| Cost of Goods | N/A | N/A | 1,142 | N/A | N/A |
| Gross Profit | 3,976 | 3,890 | 7,618 | 3,099 | 9,437 |
| Operating Expenses | 26,190 | 21,751 | 21,109 | 18,615 | 20,122 |
| Operating Income | -22,214 | -17,861 | -13,349 | -15,516 | -10,685 |
| Interest Expense | 2,221 | 2,231 | 2,140 | 2,094 | 2,100 |
| Other Income | -1,342 | 549 | 355 | 724 | -1,434 |
| Pre-tax Income | -25,777 | -19,543 | -15,134 | -16,886 | -14,219 |
| Net Income Continuous | -25,777 | -19,543 | -15,134 | -16,886 | -14,219 |
| Net Income | $-25,777 | $-19,543 | $-15,134 | $-16,886 | $-14,219 |
| EPS Basic Total Ops | -0.26 | -0.20 | -0.18 | -0.21 | -0.19 |
| EPS Basic Continuous Ops | -0.26 | -0.20 | -0.18 | -0.21 | -0.19 |
| EPS Diluted Total Ops | -0.26 | -0.20 | -0.18 | -0.21 | -0.19 |
| EPS Diluted Continuous Ops | -0.26 | -0.20 | -0.18 | -0.21 | -0.19 |
| EBITDA(a) | $-21,720 | $-17,429 | $-12,913 | $-15,057 | $-10,275 |